Litcius/Paper detail

Sorafenib maintenance after allogeneic haemopoietic stem-cell transplantation in patients with FLT3-ITD acute myeloid leukaemia: long-term follow-up of an open-label, multicentre, randomised, phase 3 trial

Li Xuan, Yu Wang, Kaibo Yang, Ruoyang Shao, Fen Huang, Zhiping Fan, Peiru Chi, Yajing Xu, Na Xu, Lan Deng, Xudong Li, Xinquan Liang, Xiaodan Luo, Pengcheng Shi, Hui Liu, Zhixiang Wang, Ling Jiang, Ren Lin, Yan Chen, Sanfang Tu, Yu Zhang, Jing Sun, Xiao‐Jun Huang, Qifa Liu

2023The Lancet Haematology68 citationsDOI

Topics & Concepts

MedicineCumulative incidenceSorafenibTransplantationInternal medicineClinical endpointPopulationHematopoietic stem cell transplantationSurgeryClinical trialOncologyHepatocellular carcinomaEnvironmental healthAcute Myeloid Leukemia ResearchChronic Myeloid Leukemia TreatmentsMyeloproliferative Neoplasms: Diagnosis and Treatment